HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation of the inhibition of allergen-specific and nonspecific skin responses by topical oxatomide].

Abstract
A double blind study against placebo was carried out in order to assess the inhibition induced by oxatomide gel in specific and aspecific cutaneous responses (prick test). Twenty allergic patients (8 M, 12 F) aged between 15 and 59 years (average 31) were treated for 7 days with oxatomide gel 5% or with placebo (2 applications a day). The results show a significant reduction of itching and of wheal size (considering either major diameter and area) only in the oxatomide group (p less than 0.01 between times and p less than 0.001 between treatments), whereas among controls itching remained unchanged and wheal size increased. During the follow-up a gradual return of wheal size to initial values in the patients treated was observed.
AuthorsG Sacerdoti, M Cardone, M Nicora
JournalGiornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia (G Ital Dermatol Venereol) Vol. 125 Issue 7-8 Pg. XXIX-XXXII (Aug 1990) ISSN: 0392-0488 [Print] Italy
Vernacular TitleValutazione dell'inibizione delle risposte cutanee allergene-specifiche e non da parte dell'oxatomide per uso topico.
PMID1688330 (Publication Type: Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
Chemical References
  • Allergens
  • Gels
  • Histamine H1 Antagonists
  • Piperazines
  • Histamine
  • oxatomide
Topics
  • Adolescent
  • Adult
  • Allergens
  • Double-Blind Method
  • Female
  • Gels
  • Histamine
  • Histamine H1 Antagonists (administration & dosage, pharmacology)
  • Humans
  • Male
  • Middle Aged
  • Piperazines (administration & dosage, pharmacology)
  • Respiratory Hypersensitivity (diagnosis, drug therapy)
  • Skin Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: